Cargando…

Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells

Radio-chemotherapy with 5-flu orouracil (5-FU) is the standard of care treatment for patients with colorectal cancer, but it is only effective for a third of them. Despite our understanding of the mechanism of action of 5-FU, drug resistance remains a significant limitation to the clinical use of 5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Anaïs, Bergeron, Danny, Vencic, Jean, Lévesque, Dominique, Paquette, Benoit, Scott, Michelle S., Boisvert, François-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981854/
https://www.ncbi.nlm.nih.gov/pubmed/35379199
http://dx.doi.org/10.1186/s12885-022-09417-3
_version_ 1784681687791173632
author Chauvin, Anaïs
Bergeron, Danny
Vencic, Jean
Lévesque, Dominique
Paquette, Benoit
Scott, Michelle S.
Boisvert, François-Michel
author_facet Chauvin, Anaïs
Bergeron, Danny
Vencic, Jean
Lévesque, Dominique
Paquette, Benoit
Scott, Michelle S.
Boisvert, François-Michel
author_sort Chauvin, Anaïs
collection PubMed
description Radio-chemotherapy with 5-flu orouracil (5-FU) is the standard of care treatment for patients with colorectal cancer, but it is only effective for a third of them. Despite our understanding of the mechanism of action of 5-FU, drug resistance remains a significant limitation to the clinical use of 5-FU, as both intrinsic and acquired chemoresistance represents the major obstacles for the success of 5-FU-based chemotherapy. In order to identify the mechanism of acquired resistance, 5-FU chemoresistance was induced in CRC cell lines by passaging cells with increasing concentrations of 5-FU. To study global molecular changes, quantitative proteomics and transcriptomics analyses were performed on these cell lines, comparing the resistant cells as well as the effect of chemo and radiotherapy. Interestingly, a very high proportion of downregulated genes were annotated as transcription factors coding for Krüppel-associated box (KRAB) domain-containing zinc-finger proteins (KZFPs), the largest family of transcriptional repressors. Among nearly 350 KRAB-ZFPs, almost a quarter were downregulated after the induction of a 5-FU-resistance including a common one between the three CRC cell lines, ZNF649, whose role is still unknown. To confirm the observations of the proteomic and transcriptomic approaches, the abundance of 20 different KZFPs and control mRNAs was validated by RT-qPCR. In fact, several KZFPs were no longer detectable using qPCR in cell lines resistant to 5-FU, and the KZFPs that were downregulated only in one or two cell lines showed similar pattern of expression as measured by the omics approaches. This proteomic, transcriptomic and genomic analysis of intrinsic and acquired resistance highlights a possible new mechanism involved in the cellular adaptation to 5-FU and therefore identifies potential new therapeutic targets to overcome this resistance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09417-3.
format Online
Article
Text
id pubmed-8981854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89818542022-04-06 Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells Chauvin, Anaïs Bergeron, Danny Vencic, Jean Lévesque, Dominique Paquette, Benoit Scott, Michelle S. Boisvert, François-Michel BMC Cancer Research Radio-chemotherapy with 5-flu orouracil (5-FU) is the standard of care treatment for patients with colorectal cancer, but it is only effective for a third of them. Despite our understanding of the mechanism of action of 5-FU, drug resistance remains a significant limitation to the clinical use of 5-FU, as both intrinsic and acquired chemoresistance represents the major obstacles for the success of 5-FU-based chemotherapy. In order to identify the mechanism of acquired resistance, 5-FU chemoresistance was induced in CRC cell lines by passaging cells with increasing concentrations of 5-FU. To study global molecular changes, quantitative proteomics and transcriptomics analyses were performed on these cell lines, comparing the resistant cells as well as the effect of chemo and radiotherapy. Interestingly, a very high proportion of downregulated genes were annotated as transcription factors coding for Krüppel-associated box (KRAB) domain-containing zinc-finger proteins (KZFPs), the largest family of transcriptional repressors. Among nearly 350 KRAB-ZFPs, almost a quarter were downregulated after the induction of a 5-FU-resistance including a common one between the three CRC cell lines, ZNF649, whose role is still unknown. To confirm the observations of the proteomic and transcriptomic approaches, the abundance of 20 different KZFPs and control mRNAs was validated by RT-qPCR. In fact, several KZFPs were no longer detectable using qPCR in cell lines resistant to 5-FU, and the KZFPs that were downregulated only in one or two cell lines showed similar pattern of expression as measured by the omics approaches. This proteomic, transcriptomic and genomic analysis of intrinsic and acquired resistance highlights a possible new mechanism involved in the cellular adaptation to 5-FU and therefore identifies potential new therapeutic targets to overcome this resistance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09417-3. BioMed Central 2022-04-04 /pmc/articles/PMC8981854/ /pubmed/35379199 http://dx.doi.org/10.1186/s12885-022-09417-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chauvin, Anaïs
Bergeron, Danny
Vencic, Jean
Lévesque, Dominique
Paquette, Benoit
Scott, Michelle S.
Boisvert, François-Michel
Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title_full Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title_fullStr Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title_full_unstemmed Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title_short Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
title_sort downregulation of krab zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981854/
https://www.ncbi.nlm.nih.gov/pubmed/35379199
http://dx.doi.org/10.1186/s12885-022-09417-3
work_keys_str_mv AT chauvinanais downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT bergerondanny downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT vencicjean downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT levesquedominique downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT paquettebenoit downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT scottmichelles downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells
AT boisvertfrancoismichel downregulationofkrabzincfingerproteinsin5fluorouracilresistantcolorectalcancercells